Dáil Éireann Debate, Friday - 6 September 2019
915. Deputy Jackie Cahill asked the Minister for Health the reason Duodopa which is very beneficial to Parkinson's sufferers was recently withdrawn by the HSE; if he will engage with a charity (details supplied) on the matter and review the decision made by the HSE; and if he will make a statement on the matter. [35302/19]
View answer932. Deputy Jan O'Sullivan asked the Minister for Health his plans to ensure that patients who have Parkinson’s disease can continue to receive a medication (details supplied) which is no longer available to them despite having been provided to those who have an advanced stage of the condition; and if he will make a statement on the matter. [35373/19]
View answerI propose to take Questions Nos. 915 and 932 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
